TrialThe international journal of neuropsychopharmacology2019

Nocturnal Gamma-Hydroxybutyrate Reduces Cortisol-Awakening Response and Morning Kynurenine Pathway Metabolites in Healthy Volunteers.

D A Dornbierer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.